This article was originally published in The Tan Sheet
Executive SummaryThe biosciences firm enters a licensing and distribution agreement with Solgar Vitamin and Herb to develop Nutrigenomx, a proprietary dietary supplement system tailored to an individual's genetic makeup. According to a Dec. 4 release, Leonia, N.J.-based Solgar will market the brand in its network of health and natural food retailers in North America beginning in 2008. The line will use Jersey City, N.J.-based GeneLink's Nutritional System...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.